Follicular lymphoma trials in United States

In United States 102 Also abroad 189

102 trials · From ClinicalTrials.gov, checked 14 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
A Phase II Study of Axicabtagene Ciloleucel, an Anti-CD19 Chimeric Antigen Receptor (CAR) Tcell Therapy, in Combination With Radiotherapy (RT) in Relapsed/Refractory Follicular Lymphoma
Where
Houston
Age
18 years and over
People
20
Run by
M.D. Anderson Cancer Center
See details and how to joinNCT06043323
Phase 2Taking people
Odronextamab for Relapsed and Refractory Large B-cell Lymphomas Before CAR-T
Where
Seattle
Age
18 years and over
People
27
Run by
University of Washington
See details and how to joinNCT06784726
Phase 2Taking people
Low Dose Mosunetuzumab for the Treatment of Patients With Indolent B-Cell Lymphoma
Where
Seattle
Age
18 years and over
People
20
Run by
University of Washington
See details and how to joinNCT06442475
Phase 1/2Taking people
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
Where
Albuquerque, Allentown, Augusta, Buffalo, Cincinnati, Cleveland, Dallas, Denver, Grand Rapids, Hackensack, Indianapolis, Iowa City, Irvine, Los Angeles, Louisville, Milwaukee, Nashville, New York, Norfolk, Omaha, Philadelphia, Pittsburgh, Richmond, Salt Lake City, San Antonio, San Diego, Shreveport, The Bronx, Washington D.C., Winston-Salem
Age
18 years and over
People
270 worldwide
Run by
Lyell Immunopharma, Inc.
See details and how to joinNCT05826535
Phase 1/2Taking people
Epcoritamab Plus Ibrutinib for the Treatment of Relapsed or Refractory Aggressive B-Cell Non-Hodgkin Lymphoma
Where
Columbus, Minneapolis, Richmond
Age
18 years and over
People
38
Run by
Yazeed Sawalha
See details and how to joinNCT06536049
Phase 2Taking people
Mosunetuzumab With Lenalidomide Augmentation as First-line Therapy for Follicular and Marginal Zone Lymphoma
Where
New Brunswick, New Haven, Providence
Age
18 years and over
People
52
Run by
Brown University
See details and how to joinNCT04792502
Phase 1Taking people
AutologousCD22 Chimeric Antigen Receptor (CAR)T Cells in w/Recurrent/Refractory B Cell Lymphomas
Where
Palo Alto
Age
18 years and over
People
148
Run by
Stanford University
See details and how to joinNCT06340737
Phase 2Taking people
HM2023-43:Ph 2 Trial of Tafasitamab With Lenalidomide+Rituximab in Treatment-naive FL and MZL
Where
Minneapolis
Age
18 years and over
People
65
Run by
Masonic Cancer Center, University of Minnesota
See details and how to joinNCT06792825
Phase 2Taking people
A Study of Mosunetuzumab Alone or With Zanubrutinib in People With Follicular Lymphoma
Where
Basking Ridge, Commack, Hackensack, Harrison, Middletown, Montvale, New York, Rockville Centre, Washington D.C.
Age
18 years and over
People
152
Run by
Memorial Sloan Kettering Cancer Center
See details and how to joinNCT05389293
Phase 1Taking people
LV20.19 CAR T-Cells in Combination With Pirtobrutinib for Relapsed, Refractory B-cell Malignancies
Where
Milwaukee
Age
18 years to 81 years
People
12
Run by
Medical College of Wisconsin
See details and how to joinNCT05990465
No phaseTaking people
Sample Collection for Ongoing Research and Product Evaluation Study - Non-Hodgkin Lymphoma (SCORE-NHL)
Where
Austin
Age
18 years and over
People
200
Run by
Natera, Inc.
See details and how to joinNCT07750886
Phase 1Taking people
This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma
Where
Buffalo, Duarte, Nashville, New York, Seattle, St Louis
Age
18 years and over
People
42
Run by
LTZ Therapeutics, Inc.
See details and how to joinNCT07121946
Phase 1Not yet taking people in United States
Epcoritamab and Pola-R-mini-CHP for the Treatment of Diffuse Large B Cell Lymphoma in Elderly or Unfit Patients
Where
Los Angeles
Age
70 years and over
People
20
Run by
Jonsson Comprehensive Cancer Center
See details and how to joinNCT07714421
Phase 1Taking people
Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma
Where
Chicago, Columbus, Duarte, New York, Philadelphia, Salt Lake City, The Bronx
Age
18 years and over
People
20
Run by
AIDS Malignancy Consortium
See details and how to joinNCT05077527
Phase 2Taking people
Odronextamab for the Treatment of Relapsed and Refractory Diffuse Large B-cell Lymphoma Before and After Chimeric Antigen Receptor T-cell Therapy
Where
Sacramento
Age
18 years and over
People
34
Run by
University of California, Davis
See details and how to joinNCT06854159
No phaseTaking people
Evaluation of Human Immune Responses Vaccination in Patients With Lymphoma
Where
Atlanta
Age
18 years and over
People
200
Run by
Emory University
See details and how to joinNCT03501576
Phase 2Taking people
Allo HSCT Using RIC and PTCy for Hematological Diseases
Where
Minneapolis
Age
Up to 75 years
People
56
Run by
Masonic Cancer Center, University of Minnesota
See details and how to joinNCT05805605
Phase 1Taking people
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
Where
Atlanta, Bethesda, Chicago, Cincinnati, Cleveland, Denver, Duarte, Durham, Houston, Ithaca, Miami, Milwaukee, New Haven, New York, Philadelphia, Salt Lake City, San Francisco, Sarasota
Age
18 years and over
People
572 worldwide
Run by
Nurix Therapeutics, Inc.
See details and how to joinNCT05131022 · EU 2023-510541-25-00
No phaseTaking people
Combating Cancer-Related Fatigue: A Personalized Supportive Care Program
Where
Chapel Hill
Age
18 years and over
People
40
Run by
UNC Lineberger Comprehensive Cancer Center
See details and how to joinNCT06860880
Phase 2Taking people
Epcoritamab Plus Standard of Care Platinum-Based Chemotherapy and Autologous Hematopoietic Cell Transplant for the Treatment of Relapsed or Refractory Large B-cell Lymphoma
Where
Sacramento
Age
18 years and over
People
25
Run by
University of California, Davis
See details and how to joinNCT06905509
No phaseTaking people
Registry of Older Patients With Cancer
Where
Boone, Chapel Hill, Greenville, Hendersonville, Morehead City, New Bern, Raleigh
Age
65 years and over
People
3,000
Run by
UNC Lineberger Comprehensive Cancer Center
See details and how to joinNCT01137825
Phase 2Taking people
Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders
Where
Minneapolis
Age
Up to 60 years
People
300
Run by
Masonic Cancer Center, University of Minnesota
See details and how to joinNCT03314974
Phase 2Taking people
Pirtobrutinib and Mosunetuzumab for the Treatment of Relapsed/Refractory Grades 1-3A Follicular Lymphoma, PROMOTE-FL Trial
Where
Seattle
Age
18 years and over
People
22
Run by
University of Washington
See details and how to joinNCT06948786
Phase 2Taking people
Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies
Where
Seattle
Age
6 months and over
People
60
Run by
Fred Hutchinson Cancer Center
See details and how to joinNCT04195633
Phase 2Taking people
Epcoritamab and Rituximab for First-line Follicular Lymphoma
Where
Boston, Columbus, Milwaukee, New York, Rochester
Age
18 years and over
People
100
Run by
Reid Merryman, MD
See details and how to joinNCT05783609